Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Asai, Hiroaki ^a   Fujiwara, Hiroshi ^a   Kitazawa, Sohei ^a   Kobayashi, Naoto ^a   Ochi, Toshiki ^a   Miyazaki, Yukihiro ^a   Ochi, Fumihiro ^a   Akatsuka, Yoshiki ^b   Okamoto, Sachiko ^c   Mineno, Junichi ^c   Kuzushima, Kiyotaka ^d   Ikeda, Hiroaki ^e   Shiku, Hiroshi ^e   Yasukawa, Masaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c TAKARA BIO INC   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; Immunotherapy; Podocytes; WT1

Indexed keywords

HLA A24 ANTIGEN; WT1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; KIDNEY FUNCTION; KIDNEY INJURY; MOUSE; NONHUMAN; PODOCYTE; TARGET CELL;

ADOPTIVE TRANSFER; ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GENETIC ENGINEERING; HLA-A24 ANTIGEN; HUMANS; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, TRANSGENIC; PODOCYTES; T-LYMPHOCYTES, CYTOTOXIC; WT1 PROTEINS;

EID: 84891528521     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-7-3     Document Type: Article

References (10)

1. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Anguille S, van Tendeloo VF, Berneman ZN, Leukemia 2012 26 2186 2196 10.1038/leu.2012.145 22652755
2. Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients. Chapuis AG, Ragnarsson GB, Nguyen HN, Chaney CN, Pufnock JS, Schmitt TM, Duerkopp N, Roberts IM, Pogosov GL, Ho WY, Ochsenreither S, Wölfl M, Bar M, Radich JP, Yee C, Greenberg PD, Sci Transl Med 2013 5 174ra27 23447018
3. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Morrison AA, Viney RL, Saleem MA, Ladomery MR, Am J Physiol Renal Physiol 2008 295 12 F17 10.1152/ajprenal.00597.2007 18385267
4. Podocytes are nonhematopoietic professional antigen-presenting cells. Goldwich A, Burkard M, Olke M, Daniel C, Amann K, Hugo C, Kurts C, Steinkasserer A, Gessner A, J Am Soc Nephrol 2013 24 906 916 10.1681/ASN.2012020133 23539760
5. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I, Cancer Res 2009 69 9003 9011 10.1158/0008-5472.CAN-09-1450 19903853
6. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Ochi T, Fujiwara H, Okamoto S, An J, Nagai K, Shirakata T, Mineno J, Kuzushima K, Shiku H, Yasukawa M, Blood 2011 118 1495 1503 10.1182/blood-2011- 02-337089 21673345
7. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R, Exp Cell Res 1997 236 248 258 10.1006/excr.1997.3739 9344605 (Pubitemid 27452369)
8. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Akatsuka Y, Goldberg TA, Kondo E, Martin EG, Obata Y, Morishima Y, Takahashi T, Hansen JA, Tissue Antigens 2002 59 502 511 10.1034/j.1399-0039.2002.590607.x 12445320 (Pubitemid 35034470)
9. Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Miyahara Y, Naota H, Wang L, Hiasa A, Goto M, Watanabe M, Kitano S, Okumura S, Takemitsu T, Yuta A, Majima Y, Lemonnier FA, Boon T, Shiku H, Clin Cancer Res 2005 11 5581 5589 10.1158/1078-0432.CCR-04-2585 16061876 (Pubitemid 41060836)
10. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. Miyazaki Y, Fujiwara H, Asai H, Ochi F, Ochi T, Azuma T, Ishida T, Okamoto S, Mineno J, Kuzushima K, Shiku H, Yasukawa M, Blood 2013 121 4894 4901 10.1182/blood-2012-11-465971 23641014